Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-02-20
1998-03-24
MacMillan, Keith
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514439, 514445, A61K 31425
Patent
active
057313369
ABSTRACT:
Provided is a method of treating multiple sclerosis employing certain aryl-substituted rhodanines.
REFERENCES:
patent: 4791126 (1988-12-01), Tanouchi et al.
patent: 4831045 (1989-05-01), Tanouchi et al.
patent: 4897406 (1990-01-01), Inoue et al.
patent: 4971996 (1990-11-01), Shiraishi et al.
patent: 5116855 (1992-05-01), Inoue et al.
patent: 5158966 (1992-10-01), Lafferty et al.
patent: 5216002 (1993-06-01), Gidda et al.
patent: 5356917 (1994-10-01), Panetta
patent: 5362733 (1994-11-01), Backstrom
Chemical Abstracts, AN 1990:491084, Prosiegel et al., Jan. 1990.
Chemical Abstracts, AN 1989:185585, Prosiegel et al., Jan. 1989.
Chemical Abstracts, AN 1989: 433306, Panetta et al., Jan. 1989.
Mohan, et al., Indian Drugs, Dec. 1983, 90-95.
Katsumi, et al., Chemical & Pharmaceutical Bulletin, vol. 34, No. 4, Apr. 1986, pp. 1619-1627. 62-29570.
J. Neuroimmunol. (1994), 50(1), 35-42.
Kingston Ann E.
Panetta Jill A.
Boone David E.
Eli Lilly and Company
MacMillan Keith
Palmberg Arleen
Taylor Douglas J.
LandOfFree
Method for treating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2289249